Increased synthesis of thromboxane A2 and expression of procoagulant activity by monocytes in response to arachidonic acid in diabetes mellitus
- 1 September 2001
- journal article
- research article
- Published by Elsevier in Prostaglandins, Leukotrienes & Essential Fatty Acids
- Vol. 65 (3) , 133-138
- https://doi.org/10.1054/plef.2001.0301
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Effect of Advanced Glycation End Product–Modified Albumin on Tissue Factor Expression by MonocytesArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- CARDIOVASCULAR SENSITIVITY CHANGES TO EICOSANOIDS IN RATS WITH EXPERIMENTALLY INDUCED DIABETES MELLITUSClinical and Experimental Pharmacology and Physiology, 1992
- Elevated Levels of Plasma and Urine Beta-Thromboglobulin or Thromboxane-B2 as Markers of Real Platelet Hyperactivation in Diabetic NephropathyPathophysiology of Haemostasis and Thrombosis, 1992
- Modifications of Monocyte Procoagulant Activity in Diabetes MellitusSeminars in Thrombosis and Hemostasis, 1991
- Thromboxane Biosynthesis and Platelet Function in Type II Diabetes MellitusNew England Journal of Medicine, 1990
- Primary platelet activation in recent-onset type 1 diabetes mellitusScandinavian Journal of Clinical and Laboratory Investigation, 1990
- Distinctive Features of Procoagulant Response of Monocytes from Diabetic PatientsPathophysiology of Haemostasis and Thrombosis, 1989
- Insulin and arachidonic acid metabolism in diabetes mellitusMetabolism, 1985
- Decreased Vascular Prostacyclin in Juvenile-Onset DiabetesNew England Journal of Medicine, 1979
- Decreased vascular prostacyclin in experimental diabetesLife Sciences, 1978